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 Abstract 
The purpose of this study was to investigate 
tetrahydropalmatine (THP), a major compound in 
Corydalis yanhusuo WT Wang (Family: Papaveraceae) and 
its effects on PTSD induced neurobehavior in the rodent 
model. The aims were to determine the effects of THP on 
anxiety, locomotion, and memory. A prospective 
experimental between groups design was used. Eighty 
rats were randomly divided into two groups, non-
stressed and stressed. They were then randomly 
subdivided into four groups: control, THP, midazolam, or 
THP and midazolam. The behavioral component was 
evaluated using the elevated plus maze (EPM) and Morris 
water maze (MWM) in a restraint/shock stress model. 
Data analysis was performed using a two-tailed 
Multivariate Analysis of Variance (MANOVA) and LSD 
post-hoc test. There were significant differences in 
anxiety between the groups (P<0.05). The PTSD stressed 
rat groups had significantly reduced time on the open 
arms of the EPM demonstrating significant increased 
anxiety compared to the control nonstressed groups. 
Data pertaining to the MWM did not demonstrate 
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statistical significance. While a one-time dose of THP was 
insufficient in providing a significant decrease in anxiety, 
a multi-dose regimen may yield more effective results. 
Future experiments should evaluate a multi-dose or 
prophylactic regimen. 
Key words: Post traumatic stress disorder; PTSD; 
Tetrahydropalmatine; THP; Neurobehavior; Rat. 
 
Introduction 
Post-traumatic stress disorder (PTSD) is one of the most 
common and devastating emotional injuries associated 
with war. Since 2008, the Military Health System (MHS) 
has recorded over 40,000 patients who have this 
emotional illness (Shiner, 2012). The emotional and 
physiological symptoms of PTSD are complex and very 
harmful to the health of military troops and their families. 
PTSD often results in symptoms of nervousness, memory 
problems, and hypervigilant responses. Since PTSD is very 
complicated, current treatments are also complicated. No 
one treatment has been found to be perfect. Furthermore, 
various treatments continue to change with additional 
therapies that include psychologists, behavior 
modifications, family involvement, and the use of 
medications.  
Herbal medications have become a significant 
alternative to traditional medicines. The use of herbal 
medicine increased 380% in the U.S. between 1990 and 
1997 (Ang-Lee, Moss, & Yuan, 2001). Corydalis yanhusuo, a 
popular perennial herb belonging to the Papaveraceae 
family has been found to decrease nervousness and 
movement in the laboratory rat. Because PTSD is 
categorized as an anxiety or nervousness disorder 
(Jankowsi, 2010), it is important to study the potential 
benefits of these herbal medications in the treatment of 
PTSD. This experiment examined tetrahydropalmatine 
(THP), a major compound in C. yanhusuo, on behaviors in 
rats with PTSD. Using the laboratory rat in experiments, 
these studies examined the possible benefits of THP.  
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The animal testing instruments, (Morris water maze and 
elevated plus maze) were used to examine the possible 
beneficial effects of THP on nervousness, movement, and 
memory. This study also examined whether THP 
interacted with a frequently administered anxiolytic 
medication, midazolam. Active duty military, reservists, 
veterans, and the general public exposed to stressful, 
traumatic circumstances, could benefit from the 
knowledge obtained from this research. 
Background 
PTSD is a complex mental disorder that may develop in 
response to traumatic experiences and is defined in the 
Diagnostic and Statistical Manual (DSM)-Fourth Edition-
Text Revised (DSM-IV-TR) as an anxiety disorder 
comprising four major criteria:  
1. Exposure to or witnessing an event that is threatening 
to one’s well-being and responding with intense fear, 
helplessness, or horror. 
2. Symptoms of re-experiencing, such as recurrent and 
intrusive memories, nightmares, a sense of reliving the 
trauma, or psychological and physiological distress when 
reminded of aspects of the trauma. 
3. Avoidance of thoughts, feelings, or reminders of the 
trauma, and the inability to recall parts of the trauma, 
withdrawal, and emotional numbing. 
4. Arousal increases, as manifested in sleep disturbance, 
irritability, difficulty concentrating, hypervigilance 
(hyperarousal), or exaggerated startle response.  
These symptoms must persist for at least one month 
after the traumatic event and result in a deficit in function 
(American Psychiatric Association, 2000). PTSD can also 
result in cognitive deficits that impair concentration, 
decision making, and memory. Interpersonal relations are 
often strained with conflict, social withdrawal and 
alienation, reduced intimacy, and impaired work 
performance. Furthermore, there are often somatic 
complaints of exhaustion, insomnia, headaches, startle 
response, hyperarousal, cardiovascular, gastrointestinal, 
and musculoskeletal disorders (Jankowsi, 2010). 
After a traumatic experience, a number of individuals 
suffer distress, mental illness, and/or PTSD (Ursano et al., 
2009). Simply stated, PTSD is the inability to forget the 
traumatic events resulting in pathology and distress. When 
PTSD symptoms present, treatment is required which 
includes psychotherapeutic and often pharmacologic 
therapies. These therapies are implemented to treat the 
symptoms of PTSD, which include intrusive thoughts or 
nightmares, anxiety, avoidance of situations similar to the 
traumatic event, and hyperarousal or startle (Ursano et al., 
2009). An assembly of professionals from the American 
Psychiatric Association developed and published practice 
guidelines for the treatment of PTSD (Ursano et al., 2009). 
They concluded that there is In a recent evidence-based 
review of these guidelines, the American Psychiatric 
Association suggests that there is a need for more effective 
pharmacological treatments, especially for veterans with 
combat-related PTSD (Benedek, 2009). 
Review of Literature 
Benzodiazepines (Midazolam) 
Benzodiazepines are frequently administered to 
patients for anxiolysis. They are used as an anticonvulsant 
and muscle relaxant. Their predominant clinical use has 
been for the treatment of anxiety (Nutt & Malizia, 2001). 
Benzodiazepines produce anxiolysis and antegrade 
amnesia and are frequently administered to patients 
perioperatively. Benzodiazepines are the most commonly 
prescribed anxiolytic drugs in the United States, and many 
patients are on long-term benzodiazepine therapy (Shader 
& Greenblatt, 1993). According to the American 
Psychiatric Association guidelines, benzodiazepines are 
viewed as possibly effective for anxiety and insomnia but 
may have a negative impact on PTSD (Benedek, 2009). 
Incidence of Herbal Supplement Use 
Complementary and alternative medicines (CAM) which 
includes herbal supplements are frequently used by 
military service personnel and their families. A study of US 
Navy and Marine Corps personnel reported that 37% use 
CAM with 15.9% taking herbal supplements (Smith et al., 
2007). Similarly, a survey of Army soldiers, retirees, and 
family members at an Army Medical Center demonstrated 
a 36% use of herbal supplements (McPherson & 
Schwenka, 2004). Herbal supplement use has increased 
rapidly as alternative treatments have multiplied 
exponentially. When compared to previous studies, 
current research indicates that 40% of U.S. consumers use 
herbal products, representing a 25% increase in a seven 
year period (Eisenberg et al., 1998). 
Many Americans are using herbal supplements in lieu of 
pharmaceuticals to treat their maladies. This is a result of 
an increase in public enthusiasm for alternative herbal 
medications in recent years. In 1997, 12% of the U.S. 
population reported using herbal medications, represent 
380% increase since 1990 (Ang-Lee et al., 2001). 
Although there is a burgeoning of herbal supplement 
use, controls and standardization are lacking. According to 
the Dietary Supplement Health and Education Act of 1994, 
there is no requirement for evidence of efficacy, safety, or 
quality control standards for supplements. This absence of 
control increases the risk of adverse effects related to 
herbal supplements (Sabar, Kaye, & Frost, 2001). The 
National Institute of Health estimates that approximately 
40% of American adults and approximately 12% of 
children used alternative medical treatments within the 
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past 12 months (Barnes, 2008). Up to 72% out of 1,539 
adults surveyed regarding their alternative therapies, 
including herbal use, do not disclose their treatment to 
healthcare providers, exacerbating the problem (Lambert, 
2008). In fact, because this undisclosed use of herbal 
medications, the Joint Commission has mandated that 
healthcare providers screen and document patients’ use of 
herbal medications at each health care visit (Joint 
Commission, 2010). This lack of data demonstrates the 
need for scientific research concerning herbal medications 
and the possible adverse effects and interactions with 
perioperative medicines. Many herbal products can 
interact with frequently used medications, including 
anesthesia, and may cause serious unforeseen 
consequences or complications (Dorman, 2001; Kaye, 
Kucera, & Sabar, 2004; Lee, Chui, Aun, Lau, & Gin, 2006). 
Need for Research 
While herbals have numerous purported benefits, there 
are no scientific reports regarding their possible 
pharmacologic and therapeutic benefits in PTSD. Patients 
with mental health conditions such as insomnia, 
depression, and anxiety turn to herbal supplements in an 
attempt to self-medicate. C. yanhusuo is an herbal 
medication/dietary supplement that warranted 
investigation for its purported anxiolytic/calming effects 
secondary to limited scientific data concerning its action. 
Corydalis yanhusuo/Tetrahydropalmatine (THP) 
Corydalis yanhusuo is a traditional Chinese herbal 
medicine that has speculated analgesic properties (Hu, Xie, 
Zhang, Wang, & Chen, 1994), antiseizure activity (Chang & 
Lin, 2001; Lin, Wang, & Young, 2002); antihypertensive 
effects (Chan, Chiu, Chen, Wu, & Cheng, 1999; Lin, Chueh, 
Hsieh, & Chen, 1996); and sedative/hypnotic effects (Zhu, 
1991). It appears that tetrahydropalmatine (THP) is the 
biologically active extract (Hong et al., 2006) and has been 
demonstrated to have antiseizure properties by reducing 
the seizure activity of kindled rats (Lin et al., 2002). THP 
may also be responsible for the antihypertensive 
properties of C. yanhusuo, as it has been shown to 
antagonize dopamine-2 receptors in the hypothalamus 
resulting in hypotension and bradycardia (Chueh, Hsieh, 
Chen, & Lin, 1995; Lin et al., 1996). Recently, our lab 
demonstrated a significant anxiolytic effect and decrement 
in motor movements with the administration of 
tetrahydropalmatine (THP), a component isolated from C. 
yanhusuo in the laboratory rat (Henkes et al., 2011). 
Currently, gene expression changes have been shown in 
dopamine, serotonin, acetylcholine, and gamma-
aminobutyric acid neurotransmitter systems when THP 
was administered in a PTSD rodent model (Ceremuga et 
al., 2013). Although there is evidence of central nervous 
system modulation, there are no studies evaluating the 
potential therapeutic properties of THP or C. yanhusuo in 
PTSD.  
There is a large void of research that definitively 
describes the pharmacodynamic site, or sites, that produce 
the mechanism of action of THP and its resultant 
behavioral effects. It was critically important to determine 
if herbal supplements, like THP, are effective 
pharmacologic agents in decreasing the negative 
neurobehavioral symptoms of PTSD.  
Background on PTSD Rodent Model 
There are various documented rodent PTSD models 
developed to determine the molecular mechanism(s) of 
PTSD. As reviewed by Lei Zhang (Zhang et al., 2006), these 
animal models have been developed in which extremely 
stressful experiences, aversive challenges, and situational 
reminders of a traumatic stress have demonstrated long-
term effects on behavioral, autonomic, and hormonal 
responses that are in parallel with many of the changes 
seen in humans with PTSD. Among these models, 
inescapable tail-shock model of traumatic stress, an animal 
model of PTSD modified from the learned helplessness 
paradigm, has been shown to mimic PTSD in terms of 
certain physiological parameters (Garrick, Morrow, Shalev, 
& Eth, 2001; Servatius, Ottenweller, & Natelson, 1995). 
Several laboratories have successfully established and 
tested the inescapable tail-shock model of stress in rats 
and verified that the behavioral and neurobiological 
alterations induced by this rat model are similar to those 
found in PTSD patients (Garrick et al., 2001; Servatius et 
al., 1995).  
Objective 
There are no data regarding the effectiveness of herbal 
supplements in the treatment of PTSD. Furthermore, no 
research exists on the effects of C. yanhusuo on PTSD. Our 
hypothesis was that administration of THP may improve 
neurobehavior in the PTSD rat model and our goal was to 
further corroborate this stringent PTSD rodent model. The 
objectives/specific aims of this study were to determine 
the effects of THP in a PTSD rodent model and confirm this 
PTSD model.  
Theoretical Framework  
The theoretical framework of this study was the 
integration of the evaluation of neurobehavioral effects of 
THP in PTSD. A 3-day restraint/shock stress induces PTSD. 
Herbal treatment with THP results in amelioration of 
neurobehavioral symptoms; i.e. decreased anxiety by 
increased time on open arms on EPM and increased 
memory on the Morris water maze instrument (see Figure 
1). 
Operational Definitions 
Three major neurobehavioral symptoms of PTSD are 
anxiety, motor movement, and memory deficit and were 
investigated in the rodent model. 
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For the purposes of this study, the following operational 
definitions were used: 
1. PTSD is defined as a condition that results from rats 
being exposed to three days of a stress regimen exposure 
consisting of a two hour per day session of immobilization 
and tail-shocks for three consecutive days (3DS) (2-hr 
sessions of 40, 2 mA tailshocks). Previous studies indicate 
that rats exposed to this stimuli have exhibited a 
consistent pattern of persistent physiological and 
behavioral abnormalities including an exaggerated startle 
response 10 days after stressor cessation and reduced 
body weight similar to PTSD (Servatius et al., 1995). 
2. Anxiety is defined as the ratio of open arm time to 
total time on the elevated plus maze (EPM). A rat was 
considered to have entered an arm via the MotorMonitor 
software. At the end of the test, the time spent on the open 
arms was expressed as a percentage of the time spent on 
both the open and the closed arms. An increase in the 
percentage of time spent in the open arms reflects 
decreased anxiety.  
3. Locomotion is defined as motor movements on the 
EPM. The EPM is networked with MotorMonitor software 
(Hamilton-Kinder, Poway, California) with laser sensors 
integrally attached to the EPM to track the number of 
entries into each arm, time spent in each arm, and total 
basic and fine motor movements. Basic motor movements 
are the simple count of beam breaks in the elevated plus 
maze. Each time a photobeam is interrupted, the basic 
movement count is increased. These movements reveal a 
gross measure of locomotion, but do not distinguish what 
type of activity is being performed. Fine motor movements 
are a compilation of small animal movements such as 
grooming, head weaves or bobs. When rats have increased 
anxiety or fear, they display freezing behaviors, or 
decreased movements (Flood, 2009; Servatius et al., 2005). 
4. Memory is defined as spatial memory as tested using 
the Morris water maze (MWM). This task is based upon the 
premise that animals have evolved an optimal strategy to 
explore their environment and escape from the water with 
a minimum amount of effort - i.e., swimming the shortest 
distance possible. The time it takes a rat to find a hidden 
platform in a water pool after previous exposure to the 
setup, using only available external cues, is determined as 
a measure of spatial memory (Wenk, 2004). 
 
Materials and methods 
A prospective, between-subjects experimental design in 
the rodent model was used to investigate the aims of this 
study. The use of laboratory rats in this study was in 
accordance with the National Institutes of Health Guide for 
the Care and Use of Laboratory Animals and received 
Institutional Animal Care and Use Committee approval 
from the United States Army Institute of Surgical Research, 
Fort Sam Houston, Texas. 
Animals 
Eighty male Sprague-Dawley rats (Harlan Sprague-
Dawley Laboratories) weighing 300-350 grams were used. 
They were housed in groups of three in polycarbonate 
‘shoebox’ cages lined with bedding and underwent a 
habituation/adaptation period for 7 days in a 
temperature-controlled environment (22+1°C, 60% 
humidity) with a light-dark cycle, receiving 12 hours of 
light (0600 hours to 1800 hours) and 12 hours of darkness 
(1800 hours to 0600 hours). They were allowed free 
access to food and water. The animals were handled for 
weighing, drug administration, and cleaning of cages only 
and were naïve to the EPM apparatus.  
Sample Size 
Rats were randomly assigned to one of eight groups of 
ten rats. Rats were assigned to the non-stressed groups or 
the 3-day restraint shock PTSD rodent model groups. 
There were four groups within the non-stressed rats 
(control, THP, midazolam, and midazolam + THP) and four 
groups in the stressed rats (control, THP, midazolam, and 
midazolam + THP) (see Table 1). 
Instruments 
3-day Restraint/Tail Shock PTSD Model 
Forty animals assigned to the PTSD groups underwent 
the 3-day restraint/shock stress, which consisted of a 2 
hour per day session of immobilization and tail-shocks for 
3 consecutive days. The animals were stressed in the 
morning (between 0800 and 1200 hours). They were 
restrained in a plexiglas tube, and 40 electric shocks (2mA, 
3 s duration) were applied at varying intervals (140–180 
 
 
Figure 1. Theoretical Framework illustrating the relationship 
between traumatic event (3 day restraint/shock) and 
tetrahydropalmatine (THP) on the development of PTSD 
symptoms: anxiety, motor movement, and memory. EPM = 
Elevated plus maze; MWM = Morris water maze 
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Table 1. Illustrates the assignment of 80 rats into the treatment groups both non-stressed and stressed. 
 Vehicle THP Midazolam Midazolam + THP 
Non-Stressed (Control) n = 10 n = 9* n = 9* n = 9* 
Stressed (PTSD) n = 9* n = 10 n = 10 n = 10 
*Attrition of one rat in each group of these groups during the experiments. 
 
 
Table 2. Overview of Experiment Design: Outlines the day-by-day progression of experiment design from day 1 to day 24 and tests 
completed on each day. 
 Acclimate Restraint/Shock 
PTSD Model 
Ten Post-
Stress Days 
MWM 
Training 
MWM 
Training 
THP/Midazolam 
intervention, EPM, and MWM 
Days 1-7 8-10 11-19 20 21 22-24 
Groups All rat 
groups 
Stressed (PTSD) rat 
groups 
All rat groups All rat 
groups 
All rat 
groups 
All rat groups 
PTSD = Post Traumatic Stress Disorder, MWM = Morris water maze, EPM = Elevated plus maze. 
s). Rats were stressed for 3 consecutive days as it has been 
previously demonstrated that repeated stress sessions for 
3 days is more effective than a single stress session in 
producing physiological and behavioral abnormalities, 
such as reduced body weight (Servatius et al., 1995). All 
animals were tested 12-14 days following the 3-day 
restraint/shock stress on Days 22-24 (see Table 2). 
Drugs 
The drugs or vehicle were delivered by subcutaneous 
injection (1ml latex free syringe w/ 27 gauge ½ inch 
needle, B-D, Franklin Lakes, NJ). Each animal received a 
subcutaneous (SQ) injection (10 rats/group) of: 1. control 
(saline); 2. THP (Latoxan, France) 20 mg/kg (Lin et al., 
2002); 3. midazolam (Versed®) 1.5 mg/kg; or 4. 
midazolam (Versed®) 1.5 mg/kg + THP (to evaluate 
interaction effects). Midazolam, a known benzodiazepine, 
was used as a positive control for its established anxiolytic 
effects on the EPM. The control (saline) group acted as a 
control. All animals received equivalent volumes of 
subcutaneous injection to total 2 ml.  
EPM Apparatus 
The EPM is an instrument utilized to measure anxiety in 
the rodent model (U. Falter, Gower, & Gobert, 1992; Lister, 
1987; Rosa, Vandresen, Calixto, Kovaleski, & Faria, 2000; 
Treit, Menard, & Royan, 1993). This model has been 
validated in previous research studies (Pellow, Chopin, 
File, & Briley, 1985). 
The EPM consists of two open arms and two closed arms 
50 centimeters (cm) in length and 10 cm in width. The 
open arms are directly opposite of each other, and 
similarly the closed arms oppose one another. The open 
arm is covered with 1 cm high Plexiglas on the side, in 
order to prevent the rodent from falling. The maze was 
placed 50 centimeters above the floor. In addition to being 
constructed of wood, the interior floor was painted with 
waterproof epoxy paint in a dark color. This minimized 
rodent stimulation, and provided a waterproof surface 
when exposed to urine and feces. The elevated plus maze 
is shaped like a cross (+), with the intersection of the four 
arms measuring 10 x 10 cm (Pellow et al., 1985). 
Thirty minutes after injection, each animal was placed in 
the center of the EPM, facing an open arm, and behavioral 
responses to anxiety were evaluated by the EPM for 5 
minutes. The EPM was networked with MotorMonitor 
software (Hamilton-Kinder, Poway, California) with laser 
sensors integrally attached to the EPM, which tracked the 
number of entries into each arm, time spent in each arm, 
and total basic and fine motor movements. Basic motor 
movements are the simple count of beam breaks in the 
EPM. Each time a photo beam is interrupted the basic 
movement count is increased. These movements reveal a 
gross measure of locomotion but do not distinguish what 
type of activity is being performed. Fine motor movements 
are a compilation of small animal movements such as 
grooming, head weaves and bobs. In addition, each EPM 
session was videotaped and the data collected by the 
MotorMonitor were validated by a blind review of the 
taped sessions. The EPM was cleaned with soap and water 
and dried between each animal trial to limit variability 
related to previous rat scent on the maze.  
The time spent on the open arms was also expressed as 
a percentage of the time spent on both the open and the 
closed arms. An increase in the percentage of time spent in 
the open arms reflected an anxiolytic effect.  
Morris Water Maze (MWM) Apparatus 
Specific aspects of spatial memory have been 
extensively studied using the Morris water maze. Animals 
have evolved an optimal strategy to explore their 
environment and escape from water using minimal effort. 
After previous exposure to the water maze setup and using 
only available external cues, the time it takes a rat to find a 
hidden platform in a pool of water is a measure of spatial 
memory (Wenk, 2004). With minor modifications, all 
animals were exposed to the two-day water maze test as 
previously described (Frick, Stillner, & Berger-Sweeney, 
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2000). In order to evaluate memory in rodents, the water 
maze test was utilized. The setup consisted of a circular 
(190 cm in diameter) water-filled tank (up to 30cm deep; 
temperature: 22±2 °C) that was used for the test. A non-
toxic dye was used to make the water opaque. The tank 
was divided into four zones. A platform (18cm×18cm) was 
submerged 2 cm below the water surface, in Zone 3. The 
test was conducted in a small room where extra-maze cues 
were kept consistent throughout the experiment. An 
overhead camera was connected to a computer to record 
the data. Over two days, all the rats were exposed to the 
setup 12 times, for training purposes. A 30-minute interval 
separated two blocks of six swims. Each rat was given a 
total of 60 seconds to randomly explore the water maze 
and find the platform by chance. If the rat did not find the 
platform by chance, guidance was provided. The rat was 
then allowed ten seconds on the platform to familiarize 
itself to the location, relative to the available visual clues in 
the room. Each swim started from a designated position to 
maintain consistency for each rat. The data recorded 
included distance, mean speed, rotations, entries, time, 
latency to first entry and platform entries. The probe test 
involved removing the platform and a single trial of 60 
seconds was performed on test day. The percentage of 
time spent in each zone was recorded. A sample trial 
where the rat swims in each zone of the Morris water maze 
and Zone 3, where the platform was located, is shown in 
Figure 2. 
 
Statistical Analysis 
All neurobehavior data were analyzed using a two-tailed 
multivariate analysis of variance (MANOVA), using IBM® 
SPSS Statistics 21. All assumptions were examined 
including homogeneity of error variances (via the Levine 
test) and normality. A determination of statistical 
significance in neurobehavior using THP in a rodent model 
was made. If significance was found, a LSD post hoc was 
used (Glaser, 2010). 
 
Results  
Elevated Plus Maze 
Data analyses were conducted using a 2-tailed 
multivariate analysis of variance and Least Significant 
Difference (LSD) post hoc test. Analysis of the ratio of open 
arm time versus total time spent in the elevated plus maze 
revealed statistically significant increases between the 
control midazolam and control vehicle group (P=0.027); 
the control midazolam and control midazolam plus THP 
group (P=0.017); the control midazolam and PTSD vehicle 
group (P=0.001); the control midazolam and PTSD THP 
group (P=0.006); and control midazolam and PTSD 
midazolam group (P=0.014). However, there was no 
significance found between the control THP and PTSD 
vehicle group (P=0.71) and the PTSD vehicle group 
compared to the PTSD THP group (P=0.530) (see Table 3 
and Figure 3). 
Basic Motor Movements 
Total number of basic (gross) and fine motor 
movements tracked during time in the EPM were analyzed. 
Analysis showed a significant increase in basic motor 
movement of rats in the control vehicle group compared to 
the control THP group (P<0.001); the control midazolam 
group (P<0.001); the control THP plus midazolam group 
(P<0.001); the PTSD THP group (P<0.001); the PTSD THP 
group (P<0.001); the PTSD THP group (P<0.001); the 
PTSD midazolam group (P=0.003); and the PTSD 
midazolam plus THP group (P<0.001). Significant increase 
in basic movement of rats was also noted in the PTSD 
vehicle group compared to the control THP group 
(P<0.001); the control midazolam group (P<0.001); the 
control midazolam plus THP group (P<0.001); the PTSD 
THP group (P<0.001); the PTSD midazolam group 
(P=0.023); and the PTSD midazolam plus THP group 
(P<0.001). Significant increases in basic motor movements 
of rats were also noted in the control midazolam plus THP 
compared to the control THP group (P=0.046); the control 
midazolam plus THP group compared to the PTSD 
midazolam plus THP group (P=0.006); the PTSD 
midazolam group compared to the control THP (P<0.001); 
the PTSD midazolam compared to the control midazolam 
(P=0.007); the PTSD midazolam group compared to the 
control midazolam plus THP group (P=0.043); the PTSD 
midazolam group compared to the PTSD THP group 
(P<0.001); and the PTSD midazolam group compared to 
the PTSD midazolam plus THP (P<0.001) (see Table 3 and 
Figure 4). 
 
Figure 2. Map of the Morris water maze, as demonstrated 
from ANY-maze® software. Zone 3 is the area where platform 
was located, and the line illustrates the path of rat searching 
for the platform. 
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Figure 3. Bar graph representing the ratio of open-arm time to total time on Elevated Plus Maze. The X axis is the treatment groups 
and the Y axis shows the calculated ratio of the mean open-arm time to total time plus or minus the standard error of the mean in 
seconds. The asterisks show the groups that showed significance. Veh = Vehicle, THP = tetrahydropalmatine, Mid = Midazolam, 
Mid+THP = Midazolam and tetrahydropalmatine, SEM = Standard Error of the Mean. 
 
 
 
 
Figure 4. Bar graph representing the mean number of basic movements as recorded by the Motor monitor software on the Elevated 
Plus Maze. The X axis is the treatment groups and the Y axis shows the mean number of basic movements plus or minus the 
standard error of the mean. The asterisks show the groups that showed significance. Veh = Vehicle, THP = tetrahydropalmatine, Mid 
= Midazolam, Mid+THP = Midazolam and tetrahydropalmatine, SEM = Standard Error of the Mean. 
 
Fine Motor Movements 
Similarly, a significant increase in fine motor movement 
of rats was found in the PTSD vehicle group compared to 
the control THP group (P<0.001); the control midazolam 
group (P<0.001); the control midazolam plus THP group 
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(P<0.001); the PTSD THP group (P<0.001); the PTSD 
midazolam group (P=0.012); and the PTSD midazolam 
plus THP (P<0.001). Other significant increases in fine 
motor movements of rats were found in the control vehicle 
group compared to the control THP group (P<0.001); the 
control midazolam group (P<0.001); the control 
midazolam plus THP group (P<0.001); the PTSD THP 
group (P<0.001); the PTSD midazolam group (P=0.001); 
and the PTSD midazolam plus THP (P<0.001). Further 
significant increases in fine motor movement of rats were 
found in the PTSD midazolam group compared to the 
control THP group (P<0.001); the control midazolam 
group (P=0.011); the PTSD vehicle group (P=0.012); the 
PTSD THP group (P=0.001); and the PTSD midazolam plus 
THP (P<0.001). Significant increases in fine motor 
movement of rats were also found in the control THP 
group compared to the control midazolam plus THP group 
(P=0.042); the control midazolam plus THP group 
compared to the PTSD midazolam plus THP group 
(P=0.003); and the control midazolam group compared to 
the PTSD midazolam plus THP group (P=0.045) (see Table 
3 and Figure 5). 
Morris Water Maze 
In the Morris Water Maze test, there were no 
statistically significant differences found between groups 
when looking at latency, time, and entries to the platform 
area or Zone 3 (see Figure 2). The nonstressed midazolam 
group had the overall highest mean time spent in Zone 3 
(M=14.51 + 0.68) and the control vehicle group had the 
lowest mean time spent in zone 3 (M=10.35 + 1.429) (see 
Table 4 and Figure 6).  
 
Discussion 
The purpose of this study was to investigate THP and its 
effect on PTSD induced neurobehavior in the rodent model 
and to further corroborate this stringent PTSD rodent 
model. This was the first study evaluating THP in a PTSD 
model. The ability of THP administered to a rodent with 
induced PTSD to alleviate the symptoms of anxiety, 
locomotion, and memory was studied. Rats were separated 
into PTSD and non-stressed groups and administered 
various pharmacological agents. The PTSD induction 
model in which rats were exposed to a two-hour 
immobilization and tail-shock session over three days was 
validated in our study. This was evidenced by a significant 
increase in the ratio of open-arm time versus total time 
when comparing the control midazolam group and all 
PTSD treatment groups (P=0.014), revealing anxiety-like 
behavior in the rats that underwent PTSD conditioning.  
The EPM was used to evaluate the amount of anxiety-
like behavior experienced by the rat (H. Falter, Persinger, 
& Chretien, 1992; Rosa et al., 2000; Shepherd, Grewal, 
Fletcher, Bill, & Dourish, 1994; Treit et al., 1993). During 
the 5-minute test, the number of entries into the open or 
closed arms, as well as the time spent in each arm, was a 
measure of anxiety-like behavior. Our results showed that 
Table 3. Table showing treatment groups, sample size, mean ratio of open arm time to total maze time (in seconds), the number of 
basic motor movements and number of fine motor movements on elevated plus maze. 
Group Sample 
Size 
Mean Ratio Open Arm/Total 
Time ± SEM 
Basic Motor 
Movement ± SEM 
Fine Motor Movement 
± SEM 
Control Vehicle 10 43.7 ± 5.8* 1103.2 ± 52.7 794.3 ± 33.9 
Control THP 9 53.6 ± 15.3 222.4 ± 53.5* 185.3 ± 40.0* 
Control Midazolam 9 77.8 ± 7.6* 391 ± 109.4* 276 ± 73.6* 
Control Midazolam + THP 9 39.9 ± 11.3* 478.1 ± 115.3* 366.3 ± 84.6* 
PTSD Vehicle 9 25.2 ± 4.2* 1017.4 ± 73.3 717.9 ± 47.3 
PTSD THP 10 34.7 ± 11* 264.5 ± 56.7* 208.4 ± 41.8* 
PTSD Midazolam 10 39.7 ± 9.3* 731.5 ± 135.1* 499.2 ± 89* 
PTSD Midazolam + THP 10 53.9 ± 14.8 130 ± 54.3* 102.8 ± 43.6* 
Data are presented as mean ± standard error of the mean. SEM = Standard Error of the Mean, THP = tetrahydropalmatine, PTSD = 
Post Traumatic Stress Disorder. *P<0.05. 
 
Table 4. Table showing treatment groups, sample size, mean time spent in zone 3 and standard error of the mean. 
Group Sample Size Mean Zone 3 Time Standard Error of the Mean 
Control Vehicle 10 10.35 1.429 
Control THP 9 13.68 1.372 
Control Midazolam 9 14.51 0.680 
Control Midazolam + THP 9 13.41 0.869 
PTSD Vehicle 9 13.29 1.546 
PTSD THP 10 11.21 1.957 
PTSD Midazolam 10 13.61 1.345 
PTSD Midazolam + THP 10 13.89 0.922 
THP = tetrahydropalmatine, PTSD = Post Traumatic Stress Disorder. 
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the control midazolam group had the higher mean 
(M=77.8) entries into the open arm compared to all other 
groups. The PTSD vehicle group had the lowest number of 
entries (M=25.2). The addition of THP did not result in any 
significant difference between the groups with a mean of 
(M=34.7). 
The MWM was used to investigate learning and memory 
in rats (Wenk, 2004). The time it takes the rats to find the 
hidden platform is the determinate of spatial memory. Our 
data showed no statistical significance with the use of THP, 
when evaluating distance, mean speed, and entries into the 
Zone 3 where the platform was located. 
Overall, evaluation of the data collected in this study did 
not support our hypothesis that THP may ameliorate the 
 
Figure 5. Bar graph representing the mean number of fine movements as recorded by the Motor monitor software on the Elevated 
Plus Maze. The X axis is the treatment groups and the Y axis shows the mean number of fine movements plus or minus the standard 
error of the mean. The asterisks show the groups that showed significance. Veh = Vehicle, THP = tetrahydropalmatine, Mid = 
Midazolam, Mid+THP = Midazolam and tetrahydropalmatine, SEM = Standard Error of the Mean. 
 
 
Figure 6. Bar graph representing the mean time spent in Zone 3 of Morris water maze plus or minus the standard error of the mean. 
The X axis is treatment groups and the Y axis is mean time spent in Zone 3 plus or minus the standard error of the mean. Veh = 
Vehicle, THP = tetrahydropalmatine, Mid = Midazolam, Mid+THP = Midazolam and tetrahydropalmatine, SEM = Standard Error of the 
Mean. 
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symptoms of PTSD. However, our experimental model was 
validated through our implemented controls. 
While a one-time dose was insufficient in providing a 
significant decrease in anxiety, a multi-dose regimen may 
yield more effective results. Future experiments should 
evaluate a multi-dose or prophylactic regimen. The timing 
of administration, such as multidose or prophylaxis, may 
yield different results. It is known that some treatments of 
PTSD (i.e. antidepressants) may require an extended 
period of time to affect neurobehavior (Dremencov et al., 
2004; Gelenberg & Chesen, 2000). Future studies of THP 
may utilize our current validated model with an extended 
dosing period, to obtain steady state for the period of time 
needed to alter neurobehavior. 
Conclusion 
PTSD is a devastating, debilitating, and costly 
neuropathologic outcome of war. It is critical that nurses 
and other health care professionals investigate treatments 
to ameliorate the neurobehavioral sequelae from PTSD. 
While the results in this study showed no significant 
difference between rats it validated the theoretic 
framework and PTSD Disease Induction Model. This model 
will be useful in future research applications. The 
neurobehavioral data gleaned from this study and future 
studies is critically important for the translation of bench 
research to clinical research in moving towards optimizing 
the treatment of patients with PTSD. 
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